Mahesh M ★ India, 2015-10-27 08:01 (3434 d 22:40 ago) Posting: # 15581 Views: 6,968 |
|
Dear All, Can you enlighten me for the below
Thanks and regards. |
ElMaestro ★★★ Denmark, 2015-10-27 10:18 (3434 d 20:24 ago) @ Mahesh M Posting: # 15582 Views: 5,792 |
|
Hi Mahesh M, ❝ – What is the steep exposure-response relationship? It means that the slope of the dose-response curve is steep. Remember that sometimes we can describe the curve roughly with the Michaelis-Menten equation, and sometimes we opt to throw a Hill constant into the game. If a drug has a steep curve than some other drug it usually implies that it will have a higher Hill slope (Hill coefficient). Steep is not a qualitative term. I cannot put a figure to it for the definition of such a drug. Everything is relative and vague. But I venture the opinion that the more pronounced the steepness, the higher the chance that a regulator would like to see monitoring of blood levels or other exposure indicators during therapy. ❝ – What is the difference between NTDI and steep exposure-response relationship? If you have an NTDI with a relatively steep exposure-response relationship then a "little" deviation in terms of exposure (dose) could easier cause the effect to be outside the therapeutic window with everything that implies for safety/efficacy. ❝ – Literature reference regarding List of drugs which have steep exposure-response relationship Can't help. — Pass or fail! ElMaestro |
nobody nothing 2015-10-27 11:51 (3434 d 18:51 ago) @ ElMaestro Posting: # 15583 Views: 5,661 |
|
See Chapter 20 "Clinical Pharmacokinetics" Rowland Tozer in 3er edition... (meanwhile there is a 4th edt.)... quite helpful to under stand basic concepts! — Kindest regards, nobody |